Differential drug survival of biologic therapies for the treatment of psoriasis: a prospective observational cohort study from the British Association of Dermatologists … RB Warren, CH Smith, ZZN Yiu, DM Ashcroft, JNWN Barker, AD Burden, ... Journal of Investigative Dermatology 135 (11), 2632-2640, 2015 | 411 | 2015 |
British Association of Dermatologists guidelines for biologic therapy for psoriasis 2017 CH Smith, ZK Jabbar‐Lopez, ZZ Yiu, T Bale, AD Burden, LC Coates, ... British Journal of Dermatology 177 (3), 628-636, 2017 | 291 | 2017 |
Factors associated with adverse COVID-19 outcomes in patients with psoriasis—insights from a global registry–based study SK Mahil, N Dand, KJ Mason, ZZN Yiu, T Tsakok, F Meynell, B Coker, ... Journal of allergy and clinical immunology 147 (1), 60-71, 2021 | 160 | 2021 |
British Association of Dermatologists guidelines for biologic therapy for psoriasis 2020: a rapid update CH Smith, ZZN Yiu, T Bale, AD Burden, LC Coates, W Edwards, ... British Journal of Dermatology 183 (4), 628-637, 2020 | 149 | 2020 |
Impact of biologic therapies on risk of major adverse cardiovascular events in patients with psoriasis: systematic review and meta‐analysis of randomized controlled trials W Rungapiromnan, ZZN Yiu, RB Warren, CEM Griffiths, DM Ashcroft British Journal of Dermatology 176 (4), 890-901, 2017 | 137 | 2017 |
Quantitative evaluation of biologic therapy options for psoriasis: a systematic review and network meta-analysis ZK Jabbar-Lopez, ZZN Yiu, V Ward, LS Exton, MFM Mustapa, ... Journal of Investigative Dermatology 137 (8), 1646-1654, 2017 | 134 | 2017 |
Systemic immunomodulatory treatments for patients with atopic dermatitis: a systematic review and network meta-analysis AM Drucker, AG Ellis, M Bohdanowicz, S Mashayekhi, ZZN Yiu, ... JAMA dermatology 156 (6), 659-667, 2020 | 121 | 2020 |
Demographics and disease characteristics of patients with psoriasis enrolled in the British Association of Dermatologists Biologic Interventions Register IYK Iskandar, DM Ashcroft, RB Warren, ZZN Yiu, K McElhone, M Lunt, ... British Journal of Dermatology 173 (2), 510-518, 2015 | 112 | 2015 |
Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19. JAMA Network Open, 2021 | 97 | 2021 |
Drug survival of adalimumab, ustekinumab and secukinumab in patients with psoriasis: a prospective cohort study from the British Association of Dermatologists Biologics and … ZZN Yiu, KJ Mason, PJ Hampton, NJ Reynolds, CH Smith, M Lunt, ... British Journal of Dermatology 183 (2), 294-302, 2020 | 95 | 2020 |
Comparison of drug discontinuation, effectiveness, and safety between clinical trial eligible and ineligible patients in BADBIR KJ Mason, JNWN Barker, CH Smith, PJ Hampton, M Lunt, K McElhone, ... JAMA dermatology 154 (5), 581-588, 2018 | 84 | 2018 |
Risk of serious infections in patients with psoriasis on biologic therapies: a systematic review and meta-analysis ZZN Yiu, LS Exton, Z Jabbar-Lopez, MFM Mustapa, EJ Samarasekera, ... Journal of Investigative Dermatology 136 (8), 1584-1591, 2016 | 83 | 2016 |
Risk of serious infection in patients with psoriasis receiving biologic therapies: a prospective cohort study from the British Association of Dermatologists Biologic … ZZN Yiu, CH Smith, DM Ashcroft, M Lunt, S Walton, R Murphy, ... Journal of Investigative Dermatology 138 (3), 534-541, 2018 | 81 | 2018 |
Systemic immunomodulatory treatments for atopic dermatitis: update of a living systematic review and network meta-analysis AM Drucker, DE Morra, D Prieto-Merino, AG Ellis, ZZN Yiu, B Rochwerg, ... JAMA dermatology, 2022 | 70 | 2022 |
Comparing the efficacy and tolerability of biologic therapies in psoriasis: an updated network meta‐analysis SK Mahil, MC Ezejimofor, LS Exton, L Manounah, AD Burden, LC Coates, ... British Journal of Dermatology 183 (4), 638-649, 2020 | 70 | 2020 |
Acne conglobata and adalimumab: use of tumour necrosis factor‐α antagonists in treatment‐resistant acne conglobata, and review of the literature ZZN Yiu, V Madan, CEM Griffiths Clinical and Experimental Dermatology 40 (4), 383-386, 2015 | 59 | 2015 |
Safety of biological therapies for psoriasis: effects on reproductive potential and outcomes in male and female patients ZZN Yiu, CEM Griffiths, RB Warren British Journal of Dermatology 171 (3), 485-491, 2014 | 51 | 2014 |
Infliximab is associated with an increased risk of serious infection in patients with psoriasis in the UK and Republic of Ireland: results from the British Association of … ZZN Yiu, DM Ashcroft, I Evans, K McElhone, M Lunt, CH Smith, S Walton, ... British Journal of Dermatology 180 (2), 329-337, 2019 | 46 | 2019 |
Early‐and late‐onset psoriasis: a cross‐sectional clinical and immunocytochemical investigation E Theodorakopoulou, ZZN Yiu, C Bundy, L Chularojanamontri, M Gittins, ... British Journal of Dermatology 175 (5), 1038-1044, 2016 | 45 | 2016 |
Drug survival associated with effectiveness and safety of treatment with guselkumab, ixekizumab, secukinumab, ustekinumab, and adalimumab in patients with psoriasis ZZN Yiu, G Becher, B Kirby, P Laws, NJ Reynolds, CH Smith, RB Warren, ... JAMA dermatology 158 (10), 1131-1141, 2022 | 41 | 2022 |